Skip to main content
SpringerLink
Log in

Medical Management of Coronary Artery Disease

  • Reference work entry
  • First Online:
PanVascular Medicine

  • 141 Accesses

Abstract

Cardiovascular diseases continue to present a major challenge in the modern era. The social and economic burden of the disease is undeniable. This chapter will focus on the medical management of both aspects of the disease, namely, stable angina and the acute coronary syndromes. We hope to present a clear, concise, and updated guidance to the reader that will aid in the grasping of the ever-evolving field of cardiovascular pharmaceuticals and medical management.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 649.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 549.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Abbreviations

ACC:

American College of Cardiology

ACE:

Angiotensin-converting enzyme

ACS:

Acute coronary syndrome

ADP:

Adenosine diphosphate

AHA:

American Heart Association

ARB:

Angiotensin receptor blocker

BMI:

Body mass index

CABG:

Coronary artery bypass grafting

CAD:

Coronary artery disease

CCB:

Calcium channel blockers

CVD:

Cardiovascular disease

DHP:

Dihydropyridine

EF:

Ejection fraction

GI:

Gastrointestinal

ICH:

Intracranial hemorrhage

IONA:

Impact of nicorandil in angina trial

IV:

Intravenous

LDL:

Low-density lipoprotein

LMWH:

Low molecular weight heparin

LV:

Left ventricle

MI:

Myocardial infarction

NICE:

National Institute of Clinical Excellence

NSTE-ACS:

Non-ST elevation acute coronary syndrome

PCI:

Percutaneous coronary interventions

PDE:

Phosphodiesterase

PPCI:

Primary PCI

rPA:

Reteplase

STEMI:

ST elevation myocardial infarction

tPA:

Tissue plasminogen activator

TIA:

Transient ischemic attack

UA:

Unstable angina

UFH:

Unfractionated heparin

References

  • Abrams J (1985) Hemodynamic effects of nitroglycerin and long-acting nitrates. Am Heart J 110(1 Pt 2):216–224

    CAS  PubMed  Google Scholar 

  • Altman R, Rouvier J, Scazziota A (2000) Secondary prevention of myocardial infarction: beneficial effect of combining oral anticoagulant plus aspirin: therapy based on evidence. Clin Appl Thromb Hemost 6(3):126–134

    Article  CAS  PubMed  Google Scholar 

  • Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr et al (2007) ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 guidelines for the management of patients with unstable angina/non-st-elevation myocardial infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. J Am Coll Cardiol 50(7):e1–e157

    Article  PubMed  Google Scholar 

  • Antithrombotic Trialists’ Collaboration (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324(7329):71–86

    Article  Google Scholar 

  • Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernandez-Aviles F et al (2007) Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 28(13):1598–1660

    Article  CAS  PubMed  Google Scholar 

  • Belardinelli L, Shryock JC, Fraser H (2006) Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine. Heart 92(Suppl 4):iv6–iv14

    CAS  PubMed  PubMed Central  Google Scholar 

  • Berger JS, Brown DL, Becker RC (2008) Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis. Am J Med 121(1):43–49

    Article  CAS  PubMed  Google Scholar 

  • Borer JS, Comerford MB, Sowton E (1976) Assessment of metoprolol, a cardioselective beta-blocking agent, during chronic therapy in patients with angina pectoris. J Int Med Res 4(1):15–22

    CAS  PubMed  Google Scholar 

  • Borer JS, Fox K, Jaillon P, Lerebours G (2003) Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial. Circulation 107(6):817–823

    Article  PubMed  Google Scholar 

  • Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R et al (2004) Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350(15):1495–1504

    Article  CAS  PubMed  Google Scholar 

  • CAPRIE Steering Committee (1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 348(9038):1329–1339

    Article  Google Scholar 

  • Chaitman BR, Pepine CJ, Parker JO, Skopal J, Chumakova G, Kuch J et al (2004) Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial. JAMA 291(3):309–316

    Article  CAS  PubMed  Google Scholar 

  • Chareonthaitawee P, Gibbons RJ, Roberts RS, Christian TF, Burns R, Yusuf S (2000) The impact of time to thrombolytic treatment on outcome in patients with acute myocardial infarction. For the CORE investigators (Collaborative Organisation for RheothRx Evaluation). Heart 84(2):142–148

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cheng JW (2001) Recognition, pathophysiology, and management of acute myocardial infarction. Am J Health Syst Pharm 58(18):1709–1718, quiz 1719-1721

    CAS  PubMed  Google Scholar 

  • De Luca G, Suryapranata H, Stone GW, Antoniucci D, Tcheng JE, Neumann FJ et al (2005) Abciximab as adjunctive therapy to reperfusion in acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. JAMA 293(14):1759–1765

    Article  PubMed  Google Scholar 

  • Eikelboom JW, Anand SS, Malmberg K, Weitz JI, Ginsberg JS, Yusuf S (2000) Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis. Lancet 355(9219):1936–1942

    Article  CAS  PubMed  Google Scholar 

  • Fibrinolytic Therapy Trialists’ (FTT) Collaborative Group (1994) Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 343(8893):311–322

    Google Scholar 

  • Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP et al (2012) ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 126(25):3097–3137

    Article  PubMed  Google Scholar 

  • Fox KM (2003) Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 362(9386):782–788

    Article  CAS  PubMed  Google Scholar 

  • Fox KA, Bassand JP, Mehta SR, Wallentin L, Theroux P, Piegas LS et al (2007) Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromes. Ann Intern Med 147(5):304–310

    Article  PubMed  Google Scholar 

  • Furberg B, Dahlqvist A, Raak A, Wrege U (1978) Comparison of the new beta-adrenoceptor antagonist, nadolol, and propranolol in the treatment of angina pectoris. Curr Med Res Opin 5(5):388–393

    Article  CAS  PubMed  Google Scholar 

  • Harrington RA, Becker RC, Ezekowitz M, Meade TW, O’Connor CM, Vorchheimer DA et al (2004) Antithrombotic therapy for coronary artery disease: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126(Suppl 3):513S–548S

    Article  CAS  PubMed  Google Scholar 

  • Heart Protection Study Collaborative Group (2002) MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360(9326):7–22

    Article  Google Scholar 

  • Henderson RA, O’Flynn N (2012) Management of stable angina: summary of NICE guidance. Heart 98(6):500–507

    Article  CAS  PubMed  Google Scholar 

  • Hong MK, Park DW, Lee CW, Lee SW, Kim YH, Kang DH et al (2009) Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis. JACC Cardiovasc Interv 2(7):679–688

    Article  PubMed  Google Scholar 

  • Huynh T, Cox JL, Massel D, Davies C, Hilbe J, Warnica W et al (2004) Predictors of intracranial hemorrhage with fibrinolytic therapy in unselected community patients: a report from the FASTRAK II project. Am Heart J 148(1):86–91

    Article  PubMed  Google Scholar 

  • Juul-Moller S, Edvardsson N, Jahnmatz B, Rosen A, Sorensen S, Omblus R (1992) Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. Lancet 340(8833):1421–1425

    Article  CAS  PubMed  Google Scholar 

  • Krikler DM (1987) Calcium antagonists for chronic stable angina pectoris. Am J Cardiol 59(3):95B–100B

    Article  CAS  PubMed  Google Scholar 

  • LIPID Study Group (1998) Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-term Intervention with Pravastatin in Ischaemic Disease. N Engl J Med 339(19):1349–1357

    Article  Google Scholar 

  • Lubsen J, Tijssen JG (1987) Efficacy of nifedipine and metoprolol in the early treatment of unstable angina in the coronary care unit: findings from the Holland Interuniversity Nifedipine/metoprolol Trial (HINT). Am J Cardiol 60(2):18A–25A

    Article  CAS  PubMed  Google Scholar 

  • McMurray JJ, Ostergren J, Swedberg K, Granger CB, Held P, Michelson EL et al (2003) Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial. Lancet 362(9386):767–771

    Article  CAS  PubMed  Google Scholar 

  • Mehta SR, Granger CB, Eikelboom JW, Bassand JP, Wallentin L, Faxon DP et al (2007) Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial. J Am Coll Cardiol 50(18):1742–1751

    Article  CAS  PubMed  Google Scholar 

  • Mehta SR, Bassand JP, Chrolavicius S, Diaz R, Eikelboom JW, Fox KA et al (2010) Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. N Engl J Med 363(10):930–942

    Article  PubMed  Google Scholar 

  • MIAMI The Trial Research Group (1985) Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. Eur Heart J 6(3):199–226

    Google Scholar 

  • Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A et al (2013) ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34(38):2949–3003

    Article  PubMed  Google Scholar 

  • Morrison LJ, Verbeek PR, McDonald AC, Sawadsky BV, Cook DJ (2000) Mortality and prehospital thrombolysis for acute myocardial infarction: a meta-analysis. JAMA 283(20):2686–2692

    Article  CAS  PubMed  Google Scholar 

  • Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA et al (2004) Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 291(9):1071–1080

    Article  CAS  PubMed  Google Scholar 

  • O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA et al (2013) ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 61(4):e78–e140

    Article  PubMed  Google Scholar 

  • Ovricenco E, Sinescu C, Dinescu S (2008) Effect of angiotensin II type 1 receptor antagonist valsartan on cardiac remodeling and left ventricular function in patients with acute ST-elevation myocardial infarction. J Med Life 1(3):323–333

    PubMed  Google Scholar 

  • Patti G, Colonna G, Pasceri V, Pepe LL, Montinaro A, Di Sciascio G (2005) Randomized trial of high loading dose of clopidogrel for reduction of periprocedural myocardial infarction in patients undergoing coronary intervention: results from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study. Circulation 111(16):2099–2106

    Article  CAS  PubMed  Google Scholar 

  • Pepine CJ, Wolff AA (1999) A controlled trial with a novel anti-ischemic agent, ranolazine, in chronic stable angina pectoris that is responsive to conventional antianginal agents. Ranolazine Study Group. Am J Cardiol 84(1):46–50

    Article  CAS  PubMed  Google Scholar 

  • Perk et al. (2012) European Guidelines on cardiovascular disease prevention in clinical practice (version 2012), European Heart Journal 33, 1635–1701

    Google Scholar 

  • Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B et al (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348(14):1309–1321

    Article  CAS  PubMed  Google Scholar 

  • Reddy BM, Weintraub HS, Schwartzbard AZ (2010) Ranolazine: a new approach to treating an old problem. Tex Heart Inst J 37(6):641–647

    PubMed  PubMed Central  Google Scholar 

  • Rodrigues EJ, Eisenberg MJ, Pilote L (2003) Effects of early and late administration of angiotensin-converting enzyme inhibitors on mortality after myocardial infarction. Am J Med 115(6):473–479

    Article  CAS  PubMed  Google Scholar 

  • Roe MT, Armstrong PW, Fox KA, White HD, Prabhakaran D, Goodman SG et al (2012) Prasugrel versus clopidogrel for acute coronary syndromes without revascularization. N Engl J Med 367(14):1297–1309

    Article  CAS  PubMed  Google Scholar 

  • Savonitto S, Ardissiono D, Egstrup K, Rasmussen K, Bae EA, Omland T et al (1996) Combination therapy with metoprolol and nifedipine versus monotherapy in patients with stable angina pectoris. Results of the international multicenter angina exercise (IMAGE) study. J Am Coll Cardiol 27(2):311–316

    Article  CAS  PubMed  Google Scholar 

  • Scandinavian Simvastatin Survival Study (1994) Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 344(8934):1383–1389

    Google Scholar 

  • Schwartz GG, Olsson AG, Ezekowitz MD, Ganz P, Oliver MF, Waters D et al (2001) Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 285(13):1711–1718

    Article  CAS  PubMed  Google Scholar 

  • Sproat TT, Lopez LM (1991) Around the beta-blockers, one more time. DICP 25(9):962–971

    CAS  PubMed  Google Scholar 

  • Stone PH, Gratsiansky NA, Blokhin A, Huang IZ, Meng L (2006) Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial. J Am Coll Cardiol 48(3):566–575

    Article  CAS  PubMed  Google Scholar 

  • Tardif JC, Ford I, Tendera M, Bourassa MG, Fox K (2005) Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. Eur Heart J 26(23):2529–2536

    Article  CAS  PubMed  Google Scholar 

  • Tardif JC, Ponikowski P, Kahan T (2009) Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial. Eur Heart J 30(5):540–548

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Taylor SH (1994) Usefulness of amlodipine for angina pectoris. Am J Cardiol 73(3):28A–33A

    Article  CAS  PubMed  Google Scholar 

  • The GUSTO Investigators (1993) An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 329(10):673–682

    Article  Google Scholar 

  • The IONA Study Group (2002) Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet 359(9314):1269–1275

    Article  Google Scholar 

  • Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V et al (2008) Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J 29(23):2909–2945

    Article  PubMed  Google Scholar 

  • van Dijk RB, Lie KI, Crijns HJ (1988) Diltiazem in comparison with metoprolol in stable angina pectoris. Eur Heart J 9(11):1194–1199

    PubMed  Google Scholar 

  • Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C et al (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361(11):1045–1057

    Article  CAS  PubMed  Google Scholar 

  • Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S et al (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357(20):2001–2015

    Article  CAS  PubMed  Google Scholar 

  • World Health Organization (2011) Global status report on noncommunicable diseases 2010. World Health Organization, Geneva

    Google Scholar 

  • Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G (2000) Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342(3):145–153

    Article  CAS  PubMed  Google Scholar 

  • Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK (2001) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345(7):494–502

    Article  CAS  PubMed  Google Scholar 

  • Yusuf S, Mehta SR, Chrolavicius S, Afzal R, Pogue J, Granger CB et al (2006) Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med 354(14):1464–1476

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiology Specialist Registrar, Department of Cardiology, Macclesfield District General Hospital, Victoria Road, Macclesfield, Cheshire, SK10 3BL, UK

    Ahmed Farag & Deoraj Zamvar

  2. Assistant Lecturer, Cairo University, Cairo, Egypt

    Ahmed Farag

  3. Consultant Cardiologist, Barnsley District General Hospital, Barnsley, UK

    Deoraj Zamvar

Authors
  1. Ahmed Farag
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Deoraj Zamvar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ahmed Farag .

Editor information

Editors and Affiliations

  1. Division of Cardiovascular Disease Department of Internal Medicine, Health Care Center Bitterfeld, Bitterfeld-Wolfen, Germany

    Peter Lanzer

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Farag, A., Zamvar, D. (2015). Medical Management of Coronary Artery Disease. In: Lanzer, P. (eds) PanVascular Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-37078-6_234

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-37078-6_234

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-37077-9

  • Online ISBN: 978-3-642-37078-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation